NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
Back to search
Official data from USPTO
ORANGEBIOMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ORANGEBIOMED
ST13
US500000099212976Class
10, 35, 42
Filing
99212976
Registration
8227809
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
04/28/2026
Trademark type
Word
Nice classes
10, 35, 42
Filing date
06/02/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Seoul, KR
Examiner
KOZAK, EVIN L
Law office
O40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Orange Biomed Co., Ltd
Representatives
April Besl Dinsmore & Shohl LLP
Technical classification
Nice Classes
Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
HbA1c monitoring cartridge unit for home use including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of medical apparatus for monitoring blood; medical test kits for HbA1c diabetes monitoring for home use; diabetic monitoring apparatus in the nature of medical test kits for diabetes monitoring for home use; HbA1c testing apparatus for diabetes monitoring in the nature of medical test kits for diabetes monitoring for home use; diabetes monitoring apparatus for analyzing HbA1c in the nature of medical test kits for diabetes monitoring for home use; HbA1c measuring apparatus for monitoring diabetes in the nature of medical test kits for diabetes monitoring for home use; biopsy needles; continuous blood glucose monitor in the nature of medical apparatus for monitoring blood glucose levels; medical apparatus and instruments other than for dental purposes for measuring blood glucose levels; medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical blood monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical apparatus for blood analysis; blood analysis apparatus for diagnosis of diabetes; blood glucose monitoring medical apparatus; medical devices for measuring blood sugar
Class 35
Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c for home use; Retail store services featuring medical test kits for HbA1c diabetes monitoring for home use; Retail store services featuring diabetes monitoring apparatus; Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c; Retail store services featuring biopsy needles; Retail store services featuring continuous blood glucose monitor; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c; Retail store services featuring medical apparatus for blood analysis; Retail store services featuring blood analysis apparatus for diagnosis of diabetes; Retail store services featuring blood glucose monitoring apparatus
Class 42
Development of diabetes measuring apparatus in the nature of product development; development of biopsy needles in the nature of product development; development of diagnostic preparation materials for medical and veterinary purposes in the nature of product development; development of medical apparatus and instruments other than for dental purposes in the nature of product development; development of medical diagnostic reagents in the nature of product development; development of medical apparatus for blood analysis in the nature of product development; development of test strips for measuring blood glucose levels in the nature of product development; development of medical diagnostic test strips for analyzing blood in the nature of product development
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/02/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/02/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/24/2025
GNRT
NON-FINAL ACTION E-MAILED
10/24/2025
CNRT
NON-FINAL ACTION WRITTEN
10/24/2025
DOCK
ASSIGNED TO EXAMINER
10/21/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2025
MAFR
APPLICATION FILING RECEIPT MAILED
06/02/2025
NWAP
NEW APPLICATION ENTERED
06/02/2025
Continuous trademark protection
Get notified about every new filing that threatens ORANGEBIOMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.